Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19

Detalles Bibliográficos
Autores principales: Tang, Kefu, Wang, Lu, Shen, Lu, He, Lin, Wu, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science China Press 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244247/
https://www.ncbi.nlm.nih.gov/pubmed/35767206
http://dx.doi.org/10.1007/s11427-021-2138-7
_version_ 1784738482446401536
author Tang, Kefu
Wang, Lu
Shen, Lu
He, Lin
Wu, Xi
author_facet Tang, Kefu
Wang, Lu
Shen, Lu
He, Lin
Wu, Xi
author_sort Tang, Kefu
collection PubMed
description
format Online
Article
Text
id pubmed-9244247
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Science China Press
record_format MEDLINE/PubMed
spelling pubmed-92442472022-06-30 Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19 Tang, Kefu Wang, Lu Shen, Lu He, Lin Wu, Xi Sci China Life Sci Letter to the Editor Science China Press 2022-06-23 2022 /pmc/articles/PMC9244247/ /pubmed/35767206 http://dx.doi.org/10.1007/s11427-021-2138-7 Text en © Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Tang, Kefu
Wang, Lu
Shen, Lu
He, Lin
Wu, Xi
Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19
title Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19
title_full Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19
title_fullStr Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19
title_full_unstemmed Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19
title_short Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19
title_sort quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with covid-19
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244247/
https://www.ncbi.nlm.nih.gov/pubmed/35767206
http://dx.doi.org/10.1007/s11427-021-2138-7
work_keys_str_mv AT tangkefu quantitativeassessmentoffibrosis4scoreandadverseclinicaloutcomesinpatientswithcovid19
AT wanglu quantitativeassessmentoffibrosis4scoreandadverseclinicaloutcomesinpatientswithcovid19
AT shenlu quantitativeassessmentoffibrosis4scoreandadverseclinicaloutcomesinpatientswithcovid19
AT helin quantitativeassessmentoffibrosis4scoreandadverseclinicaloutcomesinpatientswithcovid19
AT wuxi quantitativeassessmentoffibrosis4scoreandadverseclinicaloutcomesinpatientswithcovid19

Ejemplares similares